Sugar Beast
An indica-leaning hybrid associated with Karma Genetics, known for resinous flowers and sweet-earthy aromatics but limited verifiable data.
Sugar Beast is a relatively niche strain with a small but loyal following. Most online 'data' about its THC percentage, terpene profile, and effects comes from seed-bank marketing copy and user self-reports, not lab averages or clinical studies. The genetics story (typically credited to Karma Genetics) is plausible but poorly documented in public records. Treat the trip-report language — 'couch-lock,' 'euphoric,' 'sleepy' — as folklore that may or may not match what you'll feel from any given cut.
Overview
Sugar Beast is a cannabis cultivar most often attributed to Karma Genetics, a Dutch breeder with a documented catalogue of OG- and Kush-leaning hybrids [1]. It is described in vendor listings and community databases as an indica-dominant hybrid producing dense, resin-coated flowers with a sweet, earthy aroma — hence the 'Sugar' in the name [2].
Unlike widely studied cultivars such as 'OG Kush' or 'Blue Dream,' Sugar Beast has not been the subject of any peer-reviewed chemotyping study we could locate. Almost everything written about it traces back to seed-bank product pages and crowd-sourced strain databases. That doesn't mean the strain isn't real or worthwhile — it means you should weight the specifics accordingly. Weak / limited
Chemistry: cannabinoids and terpenes
There is no published, independent chemotype analysis of Sugar Beast in the peer-reviewed literature. No data
Vendor pages typically list THC in the high teens to low 20s and negligible CBD, which is consistent with the broader population of modern THC-dominant cultivars sold in legal markets — average flower THC in U.S. retail samples has been measured around 17–22% in recent surveys [3][4]. Without lab certificates of analysis (COAs) tied to specific batches, any single number you see attributed to 'Sugar Beast' should be read as that batch's result, not a strain-wide constant.
Terpene claims (commonly 'caryophyllene, myrcene, limonene' in user databases) are not supported by published GC data for this specific cultivar. Across cannabis broadly, terpene profiles vary substantially between phenotypes and grows of the same strain name [5], so a single 'dominant terpene' label for Sugar Beast is unreliable. Weak / limited
Reported effects
Community reports describe Sugar Beast as heavy, relaxing, and sedating, with users frequently mentioning 'couch-lock' and use before sleep [2]. These are self-selected, unblinded anecdotes. Anecdote
There are no clinical trials of Sugar Beast specifically — and to our knowledge, no clinical trials of any named recreational strain that meet modern pharmacology standards. What evidence exists for cannabis effects generally (e.g., on sleep, anxiety, pain) is based on cannabinoid content (THC, CBD) and dose, not strain names [6]. The popular idea that 'indica' reliably predicts a sedating effect while 'sativa' predicts an energetic one is not supported by chemical or clinical data [7]. Disputed
A pragmatic read: if a particular Sugar Beast cut tests high in THC and myrcene, expect effects broadly typical of high-THC flower at your tolerance and dose. The strain name itself is a weak predictor.
Lineage
Lineage for Sugar Beast is disputed and poorly documented. Disputed
Karma Genetics is the breeder most commonly credited [1], and some community sources describe parentage involving OG- and Kush-family lines, but we could not locate a primary breeder statement that pins down the exact cross with verifiable provenance. Strain databases like SeedFinder and Leafly often list parent strains without citations, and these entries are frequently copied between sites, creating an illusion of consensus [2].
If precise genetics matter to you (for breeding, legal, or medical reasons), contact the breeder directly and ask for documentation rather than relying on third-party databases.
Cultivation basics
Public cultivation notes for Sugar Beast are limited to vendor descriptions and grower forum posts. Commonly reported characteristics include:
- Flowering time: approximately 9–10 weeks indoors (vendor-reported) Weak / limited
- Structure: medium height, indica-typical branching
- Yield: described as moderate; no controlled trial data exists No data
- Resin production: heavy, which is the basis of the 'Sugar' name Anecdote
General indoor cannabis cultivation guidance — light intensity, VPD management, integrated pest management — applies here as it does to any cultivar [8]. If you're growing Sugar Beast, treat published 'strain-specific' grow tips as starting points and adjust to your phenotype and environment.
Marketing vs. reality
What the marketing says: a uniquely potent, uniquely sedating, uniquely sugar-coated indica with a defined parentage and predictable effects.
What the evidence supports:
- Sugar Beast is a real strain name in circulation, most likely originating with Karma Genetics. Weak / limited
- THC potency, terpene composition, and effects are not independently verified for this cultivar. No data
- 'Indica = sedating' is folklore, not pharmacology [7]. Disputed
- The actual effects you'll experience depend mostly on cannabinoid dose, your tolerance, route of administration, and setting — not the name on the jar [6].
If you enjoy Sugar Beast from a specific grower, that's a perfectly good reason to buy it again. Just don't expect the name alone to guarantee consistency across producers or batches.
Sources
- Practitioner Karma Genetics. Breeder catalogue and strain listings.
- Reported Leafly strain database entry for Sugar Beast (community-sourced).
- Peer-reviewed ElSohly, M. A., et al. (2021). Cannabis Potency Trends over the Last Two Decades (1995–2019). Biological Psychiatry.
- Peer-reviewed Smart, R., Caulkins, J. P., Kilmer, B., Davenport, S., & Midgette, G. (2017). Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state. Addiction, 112(12), 2167–2177.
- Peer-reviewed Smith, C. J., Vergara, D., Keegan, B., & Jikomes, N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.
- Government National Academies of Sciences, Engineering, and Medicine (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.
- Peer-reviewed Piomelli, D., & Russo, E. B. (2016). The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 1(1), 44–46.
- Book Cervantes, J. (2015). The Cannabis Encyclopedia: The Definitive Guide to Cultivation & Consumption of Medical Marijuana. Van Patten Publishing.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Caryophyllene — A peppery sesquiterpene unique among cannabis terpenes for binding directly to a cannabino...
- Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...
- OG Kush — The hazy-origin California strain that became the genetic backbone of modern American cann...